Clinical utility of phentermine/topiramate (Qsymia™) combination for the treatment of obesity
Jin Hee Shin,1 Kishore M Gadde2 1Department of Community and Family Medicine, Duke University Medical Center, 2Obesity Clinical Trials Program, Duke University Medical Center, Durham, NC, USA Abstract: Qsymia™ (Vivus Inc, Mountain View, CA, USA), a combination of phentermine and delayed-re...
Saved in:
Main Authors: | Shin JH, Gadde KM |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2013
|
Subjects: | |
Online Access: | https://doaj.org/article/8e7b8c78bbcb44519fdfc944b618afb1 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Management of obesity and cardiometabolic risk – role of phentermine/extended release topiramate
by: Sweeting AN, et al.
Published: (2014) -
Effects of Orlistat/Phentermine versus Phentermine on Vascular Endothelial Cell Function in Obese and Overweight Adults: A Randomized, Double-Blinded, Placebo-Controlled Trial
by: Kwon YJ, et al.
Published: (2021) -
Clinical utility of fixed combinations of sitagliptin–metformin in treatment of type 2 diabetes
by: Karen Barnard, et al.
Published: (2010) -
Patient considerations and clinical utility of a fixed dose combination of saxagliptin/metformin in the treatment of type 2 diabetes
by: Maffioli P, et al.
Published: (2011) -
The clinical utility of aflibercept for diabetic macular edema
by: Stewart MW
Published: (2015)